FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 38880414.
- Also identified by DOI 10.1016/j.radonc.2024.110386.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
PET is increasingly used for target volume definition in the radiotherapy of glioblastoma, as endorsed by the 2023 ESTRO-EANO guidelines. In view of its growing adoption into clinical practice and upcoming PET-based multi-center trials, this paper aims to assist in overcoming common pitfalls of FET PET-based target delineation in glioblastoma.
Medical subject headings
- Glioblastoma
- Brain Neoplasms
- Positron-Emission Tomography
- Radiotherapy Planning, Computer-Assisted